Cargando…
Adapting MRI as a clinical outcome measure for a facioscapulohumeral muscular dystrophy trial of prednisone and tacrolimus: case report
BACKGROUND: Facioscapulohumeral muscular dystrophy (FSHD) is a patchy and slowly progressive disease of skeletal muscle. MRI short tau inversion recovery (STIR) sequences of patient muscles often show increased hyperintensity that is hypothesized to be associated with inflammation. This is supported...
Autores principales: | Wang, Leo H., Johnstone, Laura M., Bindschadler, Michael, Tapscott, Stephen J., Friedman, Seth D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797109/ https://www.ncbi.nlm.nih.gov/pubmed/33422031 http://dx.doi.org/10.1186/s12891-020-03910-1 |
Ejemplares similares
-
Longitudinal study of MRI and functional outcome measures in facioscapulohumeral muscular dystrophy
por: Wang, Leo H., et al.
Publicado: (2021) -
Immunohistochemical Characterization of FacioscapulohumeralMuscular Dystrophy Muscle Biopsies
por: Statland, Jeffrey M., et al.
Publicado: (2015) -
Outcome Measures in Facioscapulohumeral Muscular Dystrophy Clinical Trials
por: Ghasemi, Mehdi, et al.
Publicado: (2022) -
Facioscapulohumeral dystrophy: the path to consensus on pathophysiology
por: Tawil, Rabi, et al.
Publicado: (2014) -
Treatment of facioscapulohumeral muscular dystrophy with Denosumab
por: Lefkowitz, Stanley S., et al.
Publicado: (2012)